86 related articles for article (PubMed ID: 1093667)
41. Bromocriptine increases plasma estradiol-17 beta concentration in amenorrhea patients with normal serum prolactin.
Seppälä M; Unnérus HA; Hirvonen E; Ranta T
J Clin Endocrinol Metab; 1976 Aug; 43(2):474-7. PubMed ID: 950375
[TBL] [Abstract][Full Text] [Related]
42. Bromocriptine in the treatment of the hyperprolactinaemia-hypogonadism syndromes.
Besser GM; Thorner MO
Postgrad Med J; 1976; 52suppl 1():64-70. PubMed ID: 959127
[No Abstract] [Full Text] [Related]
43. [Estrogen therapy of prostatic cancer. 76 cases of previously undiagnosed prostatic cancer treated with F6066 (bis-(p-acetoxyphenyl)cyclohexylidenemethane) and diethylstilbestrol--a double-blind study].
Carstensen HE; Olsen CE; Sele V; Brorson I; Jensen E; Nissen NI; Fabricius J
Nord Med; 1969 Jan; 81(4):111-4. PubMed ID: 4888811
[No Abstract] [Full Text] [Related]
44. [Treatment of Parkinson's disease with bromocriptine].
Castaigne P; Laplane D; Bousser MG; Bories F
Nouv Presse Med; 1976 Apr; 6(17):1482. PubMed ID: 1037400
[No Abstract] [Full Text] [Related]
45. The long-acting dopamine agonist pergolide mesylate for treatment of hyperprolactinaemia.
Bergh T; Nillius SJ; Wide L
Acta Eur Fertil; 1984; 15(6):421-4. PubMed ID: 6536135
[TBL] [Abstract][Full Text] [Related]
46. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group.
Webster J; Piscitelli G; Polli A; Ferrari CI; Ismail I; Scanlon MF
N Engl J Med; 1994 Oct; 331(14):904-9. PubMed ID: 7915824
[TBL] [Abstract][Full Text] [Related]
47. [Phase II study of 5'-DFUR treatment of the bladder and prostatic cancer].
Ohmori H; Matsumura Y; Ochi J; Kobashi K; Akebi N; Saika T; Nanba K; Tanahashi T; Josen T; Nasu Y
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2307-14. PubMed ID: 1834024
[TBL] [Abstract][Full Text] [Related]
48. An ergot derivative in the treatment of Parkinson's disease.
Calne DB; Shoulson I; Kartzinel R
Postgrad Med J; 1976; 52suppl 1():81-5. PubMed ID: 183198
[No Abstract] [Full Text] [Related]
49. Intolerance of bromocriptine: is metergoline a satisfactory alternative?
Casson IF; Walker BA; Hipkin LJ; Belchetz PE
Br Med J (Clin Res Ed); 1985 Jun; 290(6484):1783-4. PubMed ID: 3924253
[No Abstract] [Full Text] [Related]
50. Antitumor activity of FCE 21336, a new prolactin lowering drug, on the MXT mouse mammary carcinoma.
Zaccheo T
Cancer Lett; 1985 Sep; 28(2):237-41. PubMed ID: 4052994
[TBL] [Abstract][Full Text] [Related]
51. [Prolactin and cancer of the prostate. IV. Prolactin inhibition in the treatment of prostatic cancer].
Maganto Pavón E; Mayayo Dehesa T; Mateos Torres JA; Boronat Tormo F; Verdú Tartajo F; de Blas Gómez V
Arch Esp Urol; 1982; 35(5):312-25. PubMed ID: 6758710
[No Abstract] [Full Text] [Related]
52. Letter: Bromocriptine and spasmodic torticollis.
Lees A; Shaw KM; Stern GM
Br Med J; 1976 May; 1(6021):1343. PubMed ID: 773515
[No Abstract] [Full Text] [Related]
53. Phase II study of 6 -methylpregn-4-ene-3,11,20-trione (NSC-17256).
Ramirez G; Weiss AJ; Rochlin DB; Bisel HF
Cancer Chemother Rep; 1971 Jun; 55(3):265-8. PubMed ID: 5115847
[No Abstract] [Full Text] [Related]
54. DL-Serine bis(2-chloropropyl)carbamate ester (CB-3210; NSC-37023) for treatment of cancer patients. Preliminary results.
Falkson G; Falkson HC
Cancer Chemother Rep; 1965 Dec; 49():31-46. PubMed ID: 5322838
[No Abstract] [Full Text] [Related]
55. Clinical trial of acetylenic carbamate: 1,1-diphenyl-2-propynyl cyclohexanecarbamate (NSC-112682).
Gailani S; Blais M
Cancer Chemother Rep; 1970 Jun; 54(3):187-90. PubMed ID: 4334087
[No Abstract] [Full Text] [Related]
56. Treatment of carcinoma of the lung with 1-acetyl-2-picolinoylhydrazine (NSC-68626).
Wilson KS; Ricci JA; Grobmyer AJ
Cancer Chemother Rep; 1970 Aug; 54(4):243-4. PubMed ID: 4946008
[No Abstract] [Full Text] [Related]
57. Medical management of prostatic cancer: some current questions.
Smith PH
Eur Urol; 1980; 6(2):65-8. PubMed ID: 6987062
[TBL] [Abstract][Full Text] [Related]
58. High-dose intermittent intravenous infusion of procarbazine (NSC-77213).
Chabner BA; Sponzo R; Hubbard S; Canellos GP; Young RC; Schein PS; Devita VT
Cancer Chemother Rep; 1973; 57(3):361-3. PubMed ID: 4584487
[No Abstract] [Full Text] [Related]
59. Clinical trial of busulfan (NSC-750) in advanced carcinoma of prostate.
Arduino LJ; Mellinger GT
Cancer Chemother Rep; 1967 Sep; 51(5):295-303. PubMed ID: 4863188
[No Abstract] [Full Text] [Related]
60. [Anasarca during treatment with bromocriptine].
Thomas P; Vinti H; Pesce A; Martin P; Cassuto JP
Presse Med; 1989 Sep; 18(29):1440. PubMed ID: 2529536
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
